Jorge Rojas-Rivera

1.9k total citations
29 papers, 602 citations indexed

About

Jorge Rojas-Rivera is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Jorge Rojas-Rivera has authored 29 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Jorge Rojas-Rivera's work include Renal Diseases and Glomerulopathies (16 papers), Vasculitis and related conditions (7 papers) and Autoimmune Bullous Skin Diseases (6 papers). Jorge Rojas-Rivera is often cited by papers focused on Renal Diseases and Glomerulopathies (16 papers), Vasculitis and related conditions (7 papers) and Autoimmune Bullous Skin Diseases (6 papers). Jorge Rojas-Rivera collaborates with scholars based in Spain, United States and Italy. Jorge Rojas-Rivera's co-authors include Alberto Ortíz, Jesús Egido, Manuel Praga, Ana Ramos, Concepción de la Piedra, Alfons Segarra, Fernando C. Fervenza, Marián Goicoechea, Enrique Morales and Emilio González‐Parra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Society of Nephrology and Drugs.

In The Last Decade

Jorge Rojas-Rivera

26 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Rojas-Rivera Spain 14 408 208 119 88 70 29 602
A. J. W. Branten Netherlands 18 696 1.7× 143 0.7× 265 2.2× 134 1.5× 69 1.0× 26 1.1k
Insa E. Emrich Germany 14 269 0.7× 54 0.3× 86 0.7× 88 1.0× 71 1.0× 42 616
Torbjörn Linde Sweden 11 275 0.7× 69 0.3× 90 0.8× 62 0.7× 46 0.7× 24 629
Igor Nikolov North Macedonia 15 420 1.0× 119 0.6× 98 0.8× 56 0.6× 29 0.4× 37 621
Massimo Morosetti Italy 13 430 1.1× 92 0.4× 118 1.0× 68 0.8× 44 0.6× 57 702
John G. Vlachojannis Greece 15 326 0.8× 97 0.5× 97 0.8× 89 1.0× 36 0.5× 38 575
Günter Stein Germany 7 442 1.1× 59 0.3× 150 1.3× 51 0.6× 71 1.0× 8 704
Graciela Delgado Austria 14 322 0.8× 144 0.7× 38 0.3× 169 1.9× 98 1.4× 28 731
Hisaki Shimada Japan 11 278 0.7× 75 0.4× 50 0.4× 105 1.2× 54 0.8× 19 471
M Narita Japan 9 307 0.8× 72 0.3× 56 0.5× 63 0.7× 97 1.4× 23 628

Countries citing papers authored by Jorge Rojas-Rivera

Since Specialization
Citations

This map shows the geographic impact of Jorge Rojas-Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Rojas-Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Rojas-Rivera more than expected).

Fields of papers citing papers by Jorge Rojas-Rivera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Rojas-Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Rojas-Rivera. The network helps show where Jorge Rojas-Rivera may publish in the future.

Co-authorship network of co-authors of Jorge Rojas-Rivera

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Rojas-Rivera. A scholar is included among the top collaborators of Jorge Rojas-Rivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Rojas-Rivera. Jorge Rojas-Rivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rojas-Rivera, Jorge, Alberto Ortíz, & Fernando C. Fervenza. (2023). Novel Treatments Paradigms: Membranous Nephropathy. Kidney International Reports. 8(3). 419–431. 23 indexed citations
2.
Rojas-Rivera, Jorge, Sevcan A. Bakkaloğlu, Davide Bolignano, et al.. (2023). Chronic kidney disease: the missing concept in the 2019 EULAR/ERA-EDTA recommendations for lupus nephritis. Nephrology Dialysis Transplantation. 39(1). 151–158. 6 indexed citations
3.
Rojas-Rivera, Jorge, Clara García-Carro, M. Espino Hernández, et al.. (2023). Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN). Clinical Kidney Journal. 16(9). 1384–1402. 13 indexed citations
4.
Rojas-Rivera, Jorge, Clara García-Carro, M. Espino Hernández, et al.. (2023). Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis. Nefrología (English Edition). 43(1). 6–47. 5 indexed citations
5.
Rojas-Rivera, Jorge & Alberto Ortíz. (2021). Nefropatía membranosa primaria en la era de los autoanticuerpos y de las terapias biológicas. Medicina Clínica. 157(3). 121–129. 5 indexed citations
6.
Rojas-Rivera, Jorge, Fernando C. Fervenza, & Alberto Ortíz. (2021). Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy. Drugs. 82(2). 109–132. 15 indexed citations
7.
Gracia-Iguacel, Carolina, et al.. (2015). Uso del sevelamer en la enfermedad renal crónica. Más allá del control del fósforo. Nefrología. 35(2). 207–217. 18 indexed citations
8.
Rojas-Rivera, Jorge, Gema Fernández‐Juárez, & Manuel Praga. (2015). Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease?. Clinical Kidney Journal. 8(5). 477–481. 13 indexed citations
9.
Morales, Enrique, Eduardo Gutiérrez, Ana M Guerreiro Hernández, et al.. (2015). Preemptive kidney transplantation in elderly recipients with kidneys discarded of very old donors: A good alternative. Nefrología. 35(3). 246–255. 9 indexed citations
13.
Rojas-Rivera, Jorge, et al.. (2013). Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis. Clinical Kidney Journal. 6(5). 510–512.
14.
Gutiérrez, Eduardo, I. Zamora, José Ballarín, et al.. (2012). Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria. Journal of the American Society of Nephrology. 23(10). 1753–1760. 137 indexed citations
15.
Morales, Enrique, et al.. (2012). Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient. Clinical Kidney Journal. 5(6). 608–609. 1 indexed citations
16.
Praga, Manuel & Jorge Rojas-Rivera. (2012). Predicting outcomes in idiopathic membranous nephropathy. Nature Reviews Nephrology. 8(9). 496–498. 5 indexed citations
17.
Morales, Enrique, Jorge Rojas-Rivera, Ana Huerta, et al.. (2012). Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases. Nephrology Dialysis Transplantation. 28(2). 405–412. 43 indexed citations
18.
González‐Parra, Emilio, et al.. (2012). Vitamin D receptor activation and cardiovascular disease. Nephrology Dialysis Transplantation. 27(suppl 4). iv17–iv21. 61 indexed citations
19.
Egido, Jesús & Jorge Rojas-Rivera. (2011). Protocolo diagnóstico de leucocituria y cilindruria. Medicine - Programa de Formación Médica Continuada Acreditado. 10(82). 5590–5591. 1 indexed citations
20.
Rojas-Rivera, Jorge, Concepción de la Piedra, Ana Ramos, Alberto Ortíz, & Jesús Egido. (2010). The expanding spectrum of biological actions of vitamin D. Nephrology Dialysis Transplantation. 25(9). 2850–2865. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026